Effect of Additive Lorazepam on Patient Satisfaction as a Premedication in Diagnostic Flexible Bronchoscopy
Information source: Seoul National University Hospital
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Patient Satisfaction for Bronchoscopy
Intervention: Lorazepam (Drug); Control (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: Seoul National University Hospital Official(s) and/or principal investigator(s): Seok-Chul Yang, MD, Study Chair, Affiliation: Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine
Overall contact: Seok-Chul Yang, MD, PhD, Phone: +82-2-2072-0354, Email: scyang@snu.ac.kr
Summary
Many patients undergoing flexible bronchoscopy (FB) experience anxiety and discomfort during
the procedure. The investigators want to evaluate whether an additional Lorazepam
premedication would improve patient satisfaction for FB.
Clinical Details
Official title: Effect of Additive Lorazepam on Patient Satisfaction as a Premedication in Diagnostic Flexible Bronchoscopy
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care
Primary outcome: patient satisfaction
Secondary outcome: relationship between patient satisfaction and sleep quality, anxiety level
Detailed description:
The enrolled patients are randomized to either the control or Lorazepam groups according to
a random sample chart of numbers. The patients complete questionnaires about baseline
anxiety level and satisfaction for FB within 24 hours after the FB.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Adult patients (aged 18 years or older) admitted to the Respiratory Department
Exclusion Criteria:
- outpatient procedures
- therapeutic bronchoscopy
- expected operation or discharge within 24 hours after the FB
- sedative premedication
- endotracheal intubation with mechanical ventilation
- inability to speak Korean
Locations and Contacts
Seok-Chul Yang, MD, PhD, Phone: +82-2-2072-0354, Email: scyang@snu.ac.kr
Seoul National University Hospital, Seoul 110-744, Korea, Republic of; Recruiting Seok-Chul Yang, MD, Email: scyang@snu.ac.kr Jong Sun Park, MD, Email: jspark.im@gmail.com
Additional Information
Starting date: March 2010
Last updated: May 27, 2010
|